The diametrically opposed roles of TRIM33 in AML versus MM may reflect its differential binding partner selection, with ALC1 interaction emerging as a key determinant of its genome-protective phenotype in MM. This evidence concerns the gene TRIM33 and Miyoshi myopathy.